In addition, reliable risk prediction models are required to learn more about the combined effect of certain patterns of susceptibility factors on overall lifetime risk and response to therapy, including their role as objects of targeted therapies. Last, but not least, criteria have to be established to define when and to whom genetic testing should be offered.